Literature DB >> 25084784

Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.

Haitham W Tuffaha1, Heather Reynolds2, Louisa G Gordon3, Claire M Rickard2, Paul A Scuffham3.   

Abstract

BACKGROUND: Value of information analysis has been proposed as an alternative to the standard hypothesis testing approach, which is based on type I and type II errors, in determining sample sizes for randomized clinical trials. However, in addition to sample size calculation, value of information analysis can optimize other aspects of research design such as possible comparator arms and alternative follow-up times, by considering trial designs that maximize the expected net benefit of research, which is the difference between the expected cost of the trial and the expected value of additional information.
PURPOSE: To apply value of information methods to the results of a pilot study on catheter securement devices to determine the optimal design of a future larger clinical trial.
METHODS: An economic evaluation was performed using data from a multi-arm randomized controlled pilot study comparing the efficacy of four types of catheter securement devices: standard polyurethane, tissue adhesive, bordered polyurethane and sutureless securement device. Probabilistic Monte Carlo simulation was used to characterize uncertainty surrounding the study results and to calculate the expected value of additional information. To guide the optimal future trial design, the expected costs and benefits of the alternative trial designs were estimated and compared.
RESULTS: Analysis of the value of further information indicated that a randomized controlled trial on catheter securement devices is potentially worthwhile. Among the possible designs for the future trial, a four-arm study with 220 patients/arm would provide the highest expected net benefit corresponding to 130% return-on-investment. The initially considered design of 388 patients/arm, based on hypothesis testing calculations, would provide lower net benefit with return-on-investment of 79%. LIMITATIONS: Cost-effectiveness and value of information analyses were based on the data from a single pilot trial which might affect the accuracy of our uncertainty estimation. Another limitation was that different follow-up durations for the larger trial were not evaluated.
CONCLUSION: The value of information approach allows efficient trial design by maximizing the expected net benefit of additional research. This approach should be considered early in the design of randomized clinical trials.
© The Author(s) 2014.

Entities:  

Keywords:  Value of information; cost-effectiveness; peripheral catheters; trial design

Mesh:

Year:  2014        PMID: 25084784     DOI: 10.1177/1740774514545634

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  7 in total

1.  The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

2.  Using value of information methods to determine the optimal sample size for effectiveness trials of alcohol interventions for HIV-infected patients in East Africa.

Authors:  Lingfeng Li; Jennifer Uyei; Kimberly A Nucifora; Jason Kessler; Elizabeth R Stevens; Kendall Bryant; R Scott Braithwaite
Journal:  BMC Health Serv Res       Date:  2018-07-31       Impact factor: 2.655

3.  A Comparative Study on Efficacy and Safety of Propofol versus Dexmedetomidine in Sleep Apnea Patients undergoing Drug-Induced Sleep Endoscopy: A CONSORT-Prospective, Randomized, Controlled Clinical Trial.

Authors:  L L Zhao; H Liu; Y Y Zhang; J Q Wei; Y Han; L Han; J P Yang
Journal:  Biomed Res Int       Date:  2018-11-01       Impact factor: 3.411

4.  Value of Information Analysis Informing Adoption and Research Decisions in a Portfolio of Health Care Interventions.

Authors:  Haitham W Tuffaha; Louisa G Gordon; Paul A Scuffham
Journal:  MDM Policy Pract       Date:  2016-07-07

5.  Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive-Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome.

Authors:  Brett Doble; Peter E Langdon; Lee Shepstone; Glynis H Murphy; David Fowler; David Heavens; Aida Malovic; Alexandra Russell; Alice Rose; Louise Mullineaux; Edward C F Wilson
Journal:  MDM Policy Pract       Date:  2017-08-30

6.  How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis.

Authors:  Laura Flight; Steven Julious; Alan Brennan; Susan Todd; Daniel Hind
Journal:  Trials       Date:  2020-03-06       Impact factor: 2.279

7.  Effects of intraoperative dexmedetomidine with intravenous anesthesia on postoperative emergence agitation/delirium in pediatric patients undergoing tonsillectomy with or without adenoidectomy: A CONSORT-prospective, randomized, controlled clinical trial.

Authors:  Jun-Li Cao; Yu-Ping Pei; Jing-Qiu Wei; Yue-Ying Zhang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.